scholarly journals D-4F, an Apolipoprotein A-I Mimetic Peptide, Inhibits the Inflammatory Response Induced by Influenza A Infection of Human Type II Pneumocytes

Circulation ◽  
2004 ◽  
Vol 110 (20) ◽  
pp. 3252-3258 ◽  
Author(s):  
Brian J. Van Lenten ◽  
Alan C. Wagner ◽  
Mohamad Navab ◽  
G.M. Anantharamaiah ◽  
Eric Ka-Wai Hui ◽  
...  
2019 ◽  
Vol 93 (21) ◽  
Author(s):  
Hannah Limburg ◽  
Anne Harbig ◽  
Dorothea Bestle ◽  
David A. Stein ◽  
Hong M. Moulton ◽  
...  

ABSTRACT Cleavage of influenza virus hemagglutinin (HA) by host cell proteases is essential for virus infectivity and spread. We previously demonstrated in vitro that the transmembrane protease TMPRSS2 cleaves influenza A virus (IAV) and influenza B virus (IBV) HA possessing a monobasic cleavage site. Subsequent studies revealed that TMPRSS2 is crucial for the activation and pathogenesis of H1N1pdm and H7N9 IAV in mice. In contrast, activation of H3N2 IAV and IBV was found to be independent of TMPRSS2 expression and supported by an as-yet-undetermined protease(s). Here, we investigated the role of TMPRSS2 in proteolytic activation of IAV and IBV in three human airway cell culture systems: primary human bronchial epithelial cells (HBEC), primary type II alveolar epithelial cells (AECII), and Calu-3 cells. Knockdown of TMPRSS2 expression was performed using a previously described antisense peptide-conjugated phosphorodiamidate morpholino oligomer, T-ex5, that interferes with splicing of TMPRSS2 pre-mRNA, resulting in the expression of enzymatically inactive TMPRSS2. T-ex5 treatment produced efficient knockdown of active TMPRSS2 in all three airway cell culture models and prevented proteolytic activation and multiplication of H7N9 IAV in Calu-3 cells and H1N1pdm, H7N9, and H3N2 IAV in HBEC and AECII. T-ex5 treatment also inhibited the activation and spread of IBV in AECII but did not affect IBV activation in HBEC and Calu-3 cells. This study identifies TMPRSS2 as the major HA-activating protease of IAV in human airway cells and IBV in type II pneumocytes and as a potential target for the development of novel drugs to treat influenza infections. IMPORTANCE Influenza A viruses (IAV) and influenza B viruses (IBV) cause significant morbidity and mortality during seasonal outbreaks. Cleavage of the viral surface glycoprotein hemagglutinin (HA) by host proteases is a prerequisite for membrane fusion and essential for virus infectivity. Inhibition of relevant proteases provides a promising therapeutic approach that may avoid the development of drug resistance. HA of most influenza viruses is cleaved at a monobasic cleavage site, and a number of proteases have been shown to cleave HA in vitro. This study demonstrates that the transmembrane protease TMPRSS2 is the major HA-activating protease of IAV in primary human bronchial cells and of both IAV and IBV in primary human type II pneumocytes. It further reveals that human and murine airway cells can differ in their HA-cleaving protease repertoires. Our data will help drive the development of potent and selective protease inhibitors as novel drugs for influenza treatment.


2020 ◽  
pp. 4271-4272
Author(s):  
S. J. Bourke

The lungs can be injured by radiation used in the treatment of cancer, with the rapidly dividing endothelial cells and type II pneumocytes most affected. Immediate injury is followed by an inflammatory response and at a later stage by fibrosis. Chest radiography detects asymptomatic changes in about 50% of patients after radiotherapy. Acute radiation pneumonitis presents with cough, breathlessness, and fever about 2 months after exposure; corticosteroids are usually effective in relieving symptoms but do not prevent the subsequent development of fibrosis. Fibrosis typically develops about 6 months later, may progress for 6–24 months, but has usually stabilized by 2 years. Prevention depends on refining techniques for giving radiotherapy.


1994 ◽  
Vol 149 (3) ◽  
pp. 699-706 ◽  
Author(s):  
J L Balibrea-Cantero ◽  
J Arias-Diaz ◽  
C Garcia ◽  
J Torres-Melero ◽  
C Simon ◽  
...  

2010 ◽  
pp. 3458-3460
Author(s):  
S.J. Bourke ◽  
D.J. Hendrick

The lungs can be injured by radiation used in cancer treatment, with the rapidly dividing endothelial cells and type II pneumocytes most affected. Immediate injury is followed by an inflammatory response and at a later stage by fibrosis. Chest radiography reveals asymptomatic changes in about 50% of patients after radiotherapy. ...


2012 ◽  
Vol 206 (11) ◽  
pp. 1685-1694 ◽  
Author(s):  
V. K. Weinheimer ◽  
A. Becher ◽  
M. Tonnies ◽  
G. Holland ◽  
J. Knepper ◽  
...  

1995 ◽  
Vol 243 (1) ◽  
pp. 49-62 ◽  
Author(s):  
Heinz Fehrenbach ◽  
Andreas Schmiedl ◽  
Thorsten Wahlers ◽  
Stefan W. Hirt ◽  
Frank Brasch ◽  
...  

1997 ◽  
Vol 16 (6) ◽  
pp. 305-310 ◽  
Author(s):  
Peter HM Hoet ◽  
Maurits Demedts ◽  
Benoit Nemery

The herbicide, paraquat is highly toxic for mammals, with the lungs being the main target organ, because of the active accumulation of the compound in this organ. The cellular toxicity of paraquat has been shown to be an O2-driven process and hyperoxia is known to increase the lethality of paraquat. In this study we have examined the effect of various O2 concentrations on the toxicity of paraquat in rat and human type II pneumocytes in culture, and we have tested whether the thickness of the liquid layer above the cells would influence the toxicity of paraquat. Type II pneumocytes were isolated from rat or human lung tissue using trypsin digestion, Percoll density gradient centrifu gation and differential attachment. Adherent cells (day 2) were incubated for 20 h in different volumes of culture medium (thickness of liquid layer), whether or not in the presence of paraquat, in the presence of different O2 tensions. The viability of the cells was assessed by the release of LDH in the culture medium. In both rat and human type II pneumocytes the toxicity of paraquat was independent of the thickness of the liquid layer (2.5 to 10 mm height). The toxicity of paraquat in rat type II pneumocytes decreased from a TC50 value of 28 μM paraquat at 21% O2 to 107 μM at 10% O2 and increased to 12 μM and 8 μM at 60% and 85% O2, respectively. For human type II pneumocytes the TC50 values were 7 μM; 25 μM and > 1000 μM paraquat at 60%, 21% and 10% O2, respectively. In this study we have shown that the diffusion of O2 through a liquid layer does not limit the toxicity of paraquat and that, as in vivo, increasing O2 partial pressure enhances the toxicity of paraquat.


Sign in / Sign up

Export Citation Format

Share Document